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Androgens and estrogens are major regulators of bone metabolism in males and females, respectively (1) . Both hormones interact with growth hormone in control of the adolescent growth spurt (2) (3) (4) . After growth is completed, androgens and estrogens maintain bone mass in the adult. In women, menopause causes accelerated bone loss that can be prevented by estrogen administration (5, 6) . Treatment of postmenopausal women with androgen derivatives, synthetic anabolic steroids, produces beneficial effects on bone metabolism (7, 8) . In males, hypogonadism is associated with bone loss, which is stabilized by testosterone administration (9) .
Because previous attempts to demonstrate receptors in bone cells of experimental animals (10, 11) or humans (12) have been unsuccessful, the prevailing view has been that the action of sex steroids on skeletal tissue is mediated indirectly. Recent data, however, suggest that estrogen has a direct action. Both specific nuclear binding of estradiol and the presence of estrogen receptor mRNA were demonstrated in normal human osteoblast-like cell strains (13) and in rat and human osteogenic sarcoma cell lines (14) . Moreover, biologic effects of estrogen treatment in vitro have been demonstrated on proliferation and differentiation of normal mouse osteoblast-like cells (15) and rat osteogenic sarcoma cell lines (16) , on induction of progesterone receptors in human osteoblastlike cell strains (13) , and on induction of gene transcription for type I procollagen and transforming growth factor P3 in rat and human osteogenic sarcoma cell lines (14) .
We have investigated the possibility that bone cells contain androgen receptors as well as estrogen receptors. These studies were carried out with cultured human osteoblast-like cells by using a sensitive, nuclear binding assay for functional sex steroid receptors (17, 18) . In addition, a cDNA probe for the human androgen receptor (19) was used to determine whether human osteoblasts contained androgen receptor mRNA.
METHODS
Cell Culture. Human bone cells were cultured from fresh samples of trabecular bone obtained during orthopedic procedures, by a procedure modified from that developed by Robey and Termine (20) . These cultured cells had the typical characteristics of the osteoblast phenotype (13, 21) . In brief, residual fibrous tissue was carefully dissected from the bone samples, which were then washed and minced in phosphatebuffered saline and digested with crude bacterial collagenase (GIBCO) at 1 mg/ml in Dulbecco's modified Eagle's medium (DMEM, GIBCO) for 2 hr at 370C in a shaking water bath. These fragments were then cultured in a phenol red-free medium (GIBCO) approximately equivalent to a Ca2+-free 1:1 (vol/vol) mixture of Ham's F-12 and DMEM supplemented with 10% heat-inactivated fetal bovine serum and penicillin/streptomycin. Steroid receptor assays were routinely performed after the second passage of cells in 175-cm2 culture flasks (20-30 population doublings). Two to 3 months of culture were required to obtain the 4 million cells needed for each assay in replicate.
In experiments to assess nuclear binding of radiolabeled steroids, the medium was replaced for 48 hr by the same medium containing 20% fetal bovine serum and 2 mM Ca2'.
Twenty-four hours before receptor assay, the medium was changed to serum-free medium containing 2 mM Ca2 .
Nuclear Binding Assay. The specific nuclear binding of tritiated steroids in these cells was measured by a nuclear binding assay as described in detail previously and modified for tissue culture cells (13, 17, 18) . In brief, human osteoblastlike cells at confluence were removed by trypsinization and suspended in MCDB-202 medium (Irvine Scientific). Repli Each nuclear pellet was extracted with ethanol and the radioactivity was determined by liquid scintillation spectrometry in a LS-5801 liquid scintillation counter (Beckman). The DNA in each replicate was quantitated by a micro version (17) of the diphenylamine assay of Burton (22) 
RESULTS
Specific Nuclear Androgen Binding in Human Osteoblastlike Cells. Specific nuclear binding of the tritiated synthetic androgen [3H]R1881 (methyltrienolone) was found in 11 of 12 (92%) osteoblast-like cell strains derived from male patients and in 10 of 13 (77%) cell strains from female patients (Fig.  1 Left). For all osteoblast-like cell strains combined, androgen receptor concentration was 821 ± 140 (mean ± SEM) molecules per cell nucleus. The nuclear androgen receptor concentration in the male strains was 628 ± 124 molecules per nucleus and ranged from 0 to 1550 molecules per nucleus. The nuclear androgen receptor concentration in the female strains was 998 ± 233 molecules per nucleus and ranged from 0 to 2750 molecules per nucleus. There was, however, no statistically significant difference between the two means (0.5 > P > 0.1, Student's t test).
Measurements of estrogen receptors in osteoblast-like cell strains were extended beyond a previous report (13) (Fig. 4) . A single band at -10 kilobases was observed with mRNA from human osteoblast-like cells and from an androgen receptor-positive tissue, rat ventral prostate (lane 2), when probed with a cDNA for the human androgen receptor (18) . mRNA from hen spleen, a tissue devoid of androgen receptor binding activity, did not contain the 10-kilobase species (lane 3). Expression of androgen receptor mRNA was similar in three strains of human osteoblasts tested.
DISCUSSION
Our data provide strong evidence for the presence of androgen receptors in normal human bone cells of the osteoblast lineage. Specific nuclear binding of [3H]R1881 (methyltrienolone, a potent synthetic androgen) was found in the large majority of cell strains studied. The nuclear binding assay employed for these studies provides added specificity because it measures only functional steroid receptors. Functional receptors are defined as those that not only bind the steroid but also become activated and bind to nuclear acceptor sites (18, 27) . This event correlates with the biologic response to the steroid (18 saturable and steroid-specific as is characteristic of steroid target tissues (27) . Expression of the androgen receptor gene in these cells was confirmed by RNA blot analysis. Thus, human bone cells contain receptors for both androgen and estrogen.
Failure of earlier studies to detect sex-steroid receptors in bone cells likely resulted from methodological problems. Earlier studies were performed before it was recognized that assays using dextran-coated charcoal require the addition of molybdate and/or protease inhibitors for stabilization of low-abundance receptors and to protect against proteolytic degradation (28 (18, 30, 31) .
Whether the observed concentrations in cultured cell strains are lower than concentrations in bone cells in vivo is unknown. It is possible, however, that prolonged culture of these cells in the absence of sex steroids influenced receptor concentration or encouraged the clonal selection of cells deficient in sex-steroid receptors.
Even though the predominant circulating sex steroid in men is testosterone and the predominant circulating sex steroids in premenopausal women are estradiol and estrone, androgens and estrogens circulate in both sexes. Our findings that bone cells contain both androgen and estrogen receptors and that their concentrations in cells from male and female donors were similar for each receptor suggest that both sex 856 Biochemistry: Colvard et al. steroids contribute to the maintenance of bone mass in both sexes. This might be particularly true in postmenopausal women, whose serum estrogens fall to low levels but whose serum testosterone declines only slightly (32) .
In summary, our data suggest that both androgens and estrogens act directly on human bone cells through their respective receptor-mediated mechanisms. These findings underscore the importance of sex steroids in bone biology. Both androgen and estrogen deficiency may have important implications in the causation of osteoporosis, an enormously important public health problem.
